Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
VERACYTE, INC.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-72.0% vs price
Base Case (Median)
-50.4% vs price
Bull Case (75th pct.)
-16.0% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $10.40 | -77.3% | High (40%) |
| PE Comparable | $31.44 | -31.4% | Medium (25%) |
| Growth Trajectory DCF | $113.00 | 146.7% | Medium (20%) |
| Graham Number | $22.71 | -50.4% | Medium (40%) |
| EV/EBITDA | $15.24 | -66.7% | Medium (20%) |
| EV/FCF | $45.55 | -0.5% | Medium (20%) |
| Earnings Power Value | $8.52 | -81.4% | Medium (50%) |
Based on 7 out of 7 methods, VCYT appears overvalued at the current price of $45.80. The base case fair value of $22.71 implies 50.4% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.